Condition category
Mental and Behavioural Disorders
Date applied
30/10/2013
Date assigned
09/12/2013
Last edited
13/07/2015
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Background and study aims
Twitter is an online media dissemination tool. We, the Cochrane Schizophrenia Group (CSzG), currently have 500+ followers on Twitter and we use Twitter to disseminate links to our systematic reviews. The aim of this study is to assess whether 'tweeting' a link to the Plain Language Summary (PLS) Cochrane website (summaries.cochrane.org) increases access to the full text of The Cochrane Library review.

Participants
Full reviews by the CSzG published in The Cochrane Library but also appearing in the PLS Cochrane website.

What does the study involve?
All similar full reviews by the CSzG have been paired (83 pairs). On the three days of highest Twitter 'traffic' (Tuesday, Wednesday, Friday) one randomly selected review in the pair will be tweeted three times on that day, in three different formats - in each case with a link to the PLS within summaries.cochrane.org. Seven days after the link to the PLS has been tweeted outcomes will be gathered from routine data within Google Analytics.

What are the possible benefits and risks of participating?
Participants are reviews and not people. Benefits for the review should be wider dissemination, and citation. We envisage no clear risks to reviews being tweeted - it is, we suppose possible, that dissemination could result in the review being dismissed by the readership and longer term access and citation declining.

Where is the study run from?
The University of Nottingham, UK

When is the study starting and how long is it expected to run for?
November 2013 to June 2014.

Who is funding the study?
The University of Nottingham (UK).

Who is the main contact?
Miss Angelique Bodart
Angelique.bodart@nottingham.ac.uk

Trial website

Contact information

Type

Scientific

Primary contact

Miss Angelique Bodart

ORCID ID

Contact details

Cochrane Schizophrenia Group
Division of Psychiatry
Institute of Mental Health Building
C floor
University of Nottingham Innovation Park
Triumph Road
Nottingham
NG7 2TU
United Kingdom
+44 (0)115 823 1274
angelique.bodart@nottingham.ac.uk

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

N/A

Study information

Scientific title

Measuring the impact of tweeting Cochrane Schizophrenia Group systematic reviews

Acronym

TweetSz

Study hypothesis

Tweeting Cochrane systematic reviews about schizophrenia increases the number of 'views' of the full text, compared to not tweeting.

Ethics approval

None required

Study design

Non-blinded parallel-arm randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised parallel trial

Trial setting

Other

Trial type

Other

Patient information sheet

N/A

Condition

Schizophrenia

Intervention

Intervention. Two groups of reviews, the Tweet group and the control or Non-tweet group. Systematic reviews in the Tweet group will have a link to their Plain Language Summary (PLS) in summaries.cochrane.org tweeted in Twitter with text about the review. Each review will be tweeted three times on the same day at 10:30, 12:30 and 2:30. The text for each of the three tweets will be in the form of: the title of the review as it is in summaries.cochrane.org; a modified extract from the results or discussion sections of the abstract; a question formulated from the contents of the PLS.
Randomisation: Cochrane Schizophrenia Group systematic reviews were paired (non-blinded) with similar reviews (based on subject relevance or clinical relevance) as best as possible. The order of the pairs on the spreadsheet were randomised within Excel (RAND). The reviews in the pair were then randomised to decide which group they should be ascribed to using an online randomisation tool (http://www.randomizer.org/). Both were completed blindly by another member of the study. The day on which the Tweet group reviews were disseminated on Twitter was also randomised using an online randomisation tool (http://www.randomizer.org/), again blindly by another member of the study.

Intervention type

Other

Phase

Not Specified

Drug names

Primary outcome measures

All gathered using Google Analytics for each pair of reviews.
1. 'Unique page views' and 'Entrance' to PLS pages
2. 'Unique page views' for the external link to full Cochrane review in 'thecochranelibrary.com'
The results, measured through Google Analytics, will be recorded one week after each review has been tweeted.

Secondary outcome measures

All gathered using Google Analytics for each pair of reviews.
1. 'Page views' to PLS pages
2. 'Page views' for the external link to full Cochrane review in 'thecochranelibrary.com'

Overall trial start date

12/11/2013

Overall trial end date

30/06/2014

Reason abandoned

Eligibility

Participant inclusion criteria

Published full text Cochrane Schizophrenia Group (CSzG) systematic reviews that appear in thecochranelibrary.com and with a Plain Language Summary (PLS) in summaries.cochrane.org.

Participant type

Other

Age group

Other

Gender

Not Specified

Target number of participants

166

Participant exclusion criteria

1. Unpublished CSzG reviews
2. Published protocol CSzG reviews that appear in thecochranelibrary.com
3. Any CSzG review that is not relevant to schizophrenia

Recruitment start date

12/11/2013

Recruitment end date

30/06/2014

Locations

Countries of recruitment

United Kingdom

Trial participating centre

Cochrane Schizophrenia Group
Nottingham
NG7 2TU
United Kingdom

Sponsor information

Organisation

Nottinghamshire Healthcare NHS Trust (UK)

Sponsor details

Duncan Macmillan House
Porchester Road
Nottingham
NG3 6AA
United Kingdom
-
abc@email.com

Sponsor type

University/education

Website

Funders

Funder type

University/education

Funder name

The University of Nottingham (UK) - intramural funding

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

2015 protocol in: http://www.ncbi.nlm.nih.gov/pubmed/26159452

Publication citations

Additional files

Editorial Notes